Pharmacogenomics holds promise for personalized dementia therapies

Pharmacogenomics-based studies in the research for personalized therapeutics for dementia

Hearing aids may slow mental decline in those at higher risk of dementia, study finds

Doctors have long suspected that hearing loss in older adults hastens dementia, the cognitive decline associated with aging. A new study published in The Lancet

July 18, 2023

Valneva adjusts 2023 financial guidance after priority voucher sale delay – Pharmaceutical Technology

Share this article The secondary market for priority review vouchers currently sits at around $100m. Image credit: Shutterstock/mundissima. Valneva has adjusted its financial guidance for

January 2, 2024

Opinion | Our Patients Need Us to Stand Up to Big Oil

Welcome to Climate Checkup, a new MedPage Today column on climate change and well-being, authored by experts affiliated with the Medical Society Consortium on Climate

December 14, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.